Brind.

Swiss National Bank and DekaBank increased their stakes in AstraZeneca shares on July 29, 2026.

1 report, 1 independent Updated Jul 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Swiss National Bank AstraZeneca

Keep exploring

The entities involved

Swiss National Bank
central bank of Switzerland
- Rumors suggest Iran is extending its conflict into the Indian Ocean, causing market volatility and creating risks for the Swiss National Bank due to actions around the Hormuz Strait.Thu 17:09
- Divergent central bank policies affect currency pair valuation.Thu 16:15
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52

Related events

First Financial Bank, Swiss National Bank, and Renaissance Technologies reported various stake changes and holdings updates during Q1 2026.Aug 10
The Swiss National Bank is involved in the development of a new payment system.Aug 28
Norges Bank and Swiss National Bank acquired new stakes in T-Mobile US shares, with disclosures made to the Securities and Exchange Commission.Jul 19

Coverage

Newest first; wire copies grouped

Jul 29tickerreport.com